I believe I am on record in the belief that the makers of anitcholesterol drugs will be having their last hurrah soon, and that they will find some way of extending the use of their drugs. One way is to find new indications for their use, another is to find a severe need for the product that can justify side effects, especially if some seem about to come to light.
One has to wonder how this study relates to recent reports that aggressively lowering cholesterol can affect cognitive function by removing cholesterols used by the brain to transmit information, and others that certain anticholesterol prescription products can even cause physical mobility disfunction.
Unless you are in a strong danger category, one would have to wonder whether waiting for more studies might be an appropriate approach to consider.